RJ

Ravi Kumar Jalluri

IN Incyte: 15 patents #61 of 356Top 20%
SP Signal Pharmaceuticals: 2 patents #134 of 207Top 65%
CN CNRS: 1 patents #3,857 of 11,908Top 35%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
Overall (All Time): #214,937 of 4,157,543Top 6%
20
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12351581 Compounds for FGFR inhibition Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Martha E. Rodriguez +9 more 2025-07-08
12281122 PI3K inhibitors Payal Chatterjee, Mark Joseph Chicarelli, Michael L. Conner, John P. Fischer, Jennifer Fulton +14 more 2025-04-22
11926630 Tertiary alcohols as PI3K-γ inhibitors Brent Douty, Andrew W. Buesking, David M. Burns, Andrew P. Combs, Nikoo Falahatpisheh +7 more 2024-03-12
11773102 Heterocyclic compounds as PI3K-γ inhibitors Artem Shvartsbart, Stacey Shepard, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh +4 more 2023-10-03
11225486 Tertiary alcohols as PI3K-γ inhibitors Brent Douty, Andrew W. Buesking, David M. Burns, Andrew P. Combs, Nikoo Falahatpisheh +7 more 2022-01-18
11091491 Heterocyclic compounds as PI3K-y inhibitors Artem Shvartsbart, Stacey Shepard, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh +4 more 2021-08-17
10738057 Tertiary alcohols as PI3K-γ inhibitors Brent Douty, Andrew W. Buesking, David M. Burns, Andrew P. Combs, Nikoo Falahatpisheh +7 more 2020-08-11
10472368 Heterocyclic compounds as PI3K-γ inhibitors Artem Shvartsbart, Stacey Shepard, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh +4 more 2019-11-12
10065963 Heterocyclic compounds as PI3K-γ inhibitors Artem Shvartsbart, Stacey Shepard, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh +2 more 2018-09-04
9440958 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases Yun-Long Li, Jincong Zhuo, David M. Burns, Wenqing Yao 2016-09-13
8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases Yun-Long Li, Jincong Zhuo, David M. Burns, Wenqing Yao 2014-10-07
8415362 Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors James D. Rodgers, Stacey Shepard, Thomas P. Maduskuie, Jr., Haisheng Wang, Nikoo Falahatpisheh +3 more 2013-04-09
8143251 Triazolotriazines as kinase inhibitors Jincong Zhuo, Colin Zhang, Meizhong Xu, Ding-Quan Qian, Wenqing Yao 2012-03-27
7973041 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases Yun-Long Li, Jincong Zhuo, David M. Burns, Wenqing Yao 2011-07-05
7915408 Triazolotriazines as kinase inhibitors Jincong Zhuo, Colin Zhang, Meizhong Xu, Ding-Quan Qian, Wenqing Yao 2011-03-29
7683060 Triazolotriazines as kinase inhibitors Jincong Zhuo, Colin Zhang, Meizhong Xu, Ding-Quan Qian, Wenqing Yao 2010-03-23
7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases Yun-Long Li, Jincong Zhuo, David M. Burns, Wenqing Yao 2009-02-17
6610684 Fused azepinone cyclin dependent kinase inhibitors Daniel W. Zaharevitz, Rick Gussio, Edward A. Sausville, Conrad Kunick, Laurent Meijer 2003-08-26
6372739 Compounds and methods for modulation of estrogen receptors Bernd Stein, David Wesley Anderson, Leah M. Gayo-Fung, Mary Doubleday, Graziella I. Shevlin +4 more 2002-04-16
6291456 Compounds and methods for modulation of estrogen receptors Bernd Stein, David Wesley Anderson, Leah M. Gayo-Fung, May S. Kung Sutherland, Mary Doubleday +5 more 2001-09-18